Thursday, June 12, 2014 3:42:01 AM
Here's the news released last night by Zalicus's partner Epirus that shows superiority over J&J's drug Remicade:
http://www.epirusbiopharma.com/investors/investors-press-releases-2014-06-11.php
And here's the Link to the market potential (scroll down the page and look for Remicade sales in 2013):
http://www.usatoday.com/story/money/markets/2013/10/22/three-best-selling-drugs/3149997/
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM